Introduction
============

Recurrent aphthous stomatitis (RAS), or recurrent aphthous ulcer (RAU), is one of the most common oral diseases, with an estimated prevalence of 25%.[@b1-dddt-10-107] Many factors may be involved in its progression, such as genetic predisposition, immunological abnormalities, microbial infection, psychological stress, and hormonal state.[@b2-dddt-10-107] Since the etiology and pathogenesis of RAS remains unclear, there is currently no consensus regarding a definitive curative therapy. The commonly accepted treatment strategy is to lessen the pain and duration of lesions.[@b3-dddt-10-107] Topical corticosteroids, antibiotics, and analgesics are highly recommended for patients with RAS.[@b4-dddt-10-107] However, longer treatment and frequent exposure to these medications may cause fungal infection and drug resistance, which may further lead to more severe adverse effects or even life-threatening complications.[@b5-dddt-10-107]

Natural herbal medicines as an alternative therapy for RAS have been widely used in many countries for decades.[@b6-dddt-10-107]--[@b8-dddt-10-107] Clinical studies on the use of such remedies have reported favorable benefits to patients by reducing the discomfort and duration of ulcers.[@b8-dddt-10-107]--[@b11-dddt-10-107] However, no evidence-based reviews regarding the efficacy and safety of the topical application of these medicines on RAS have been available in the literature to date. Therefore, we conducted this analysis to evaluate the efficacy and safety of topical treatment with natural herbal medicines on RAS.

Materials and methods
=====================

Database and search strategy
----------------------------

This study was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines.[@b12-dddt-10-107] All clinical trials that reported the effect of topical treatment with natural herbal medicines on RAS were selected in the Chinese National Knowledge Infrastructure, the Chinese Biomedical Literature Database, the Chinese Scientific Journal Database (VIP), WANFANG data (WANFANG), PubMed, Excerpta Medica dataBASE (EMBASE), Science Citation Index (SCI), Current Controlled Trials (CCT), and the Cochrane Central Register of Controlled Trials in the Cochrane Library (up to April 2015). Publication language was confined to Chinese and English. The following terms were searched individually or combined: "Chinese patent medicine", "Chinese patent drugs", "traditional Chinese medicine", "Chinese herbology", "Chinese medicine", "Chinese material medica", "Chinese herbs", "Chinese herbal medicine", "natural herbal medicine", "Chin Tradit Pat Med", "herbal medicine", "recurrent aphthous ulcer", "recurrent aphthous stomatitis", "recurrent oral ulcer", and "recurrent oral ulceration". Manual searching was used as a complementation.

Inclusion and exclusion criteria
--------------------------------

### Inclusion criteria

Randomized controlled trials (RCTs) and clinical controlled trials (CCTs) that evaluated the efficacy and safety of topical treatment with natural herbal medicines on RAS were collected. In accordance with "The diagnosis and management of recurrent aphthous stomatitis: a consensus approach",[@b13-dddt-10-107] patients meeting the diagnostic criteria for RAS were included, with no restrictions on age, sex, or race. Patients in the experimental group received natural herbal medicines locally, without combined topical Western medications or systemic administration. Patients in the control group had to receive placebo treatment, chlorhexidine rinse. The outcome measures included the assessment of ulcer size, lesion duration, and remission of pain.

### Exclusion criteria

Studies which there was duplication of study subjects were excluded, as were case reports or clinical observations without control groups, reviews, workshop summaries, translated papers or abstracts, animal studies, research reports without relevant or adequate information on participants, and interventions.

Data extraction and quality assessment
--------------------------------------

Two independent reviewers (CL Li and HL Huang) identified studies using the search strategy. If the eligibility of a study was not unanimous, a third reviewer party (H Hua and WC Wang) was consulted. Data were extracted from the included studies as follows: journal citation, author, year of publication, title, sample size, mediations, methodological details, therapeutic duration, and clinical outcomes.

The quality of the enrolled publications was assessed according to the *Cochrane Handbook for Systemic Review of Interventions*, Version 5.1.0, and Rev Man 5.3 software.[@b14-dddt-10-107] The assessment criteria were random sequence generation (selection bias), allocation concealment (selection bias), blinding of participants and personnel (performance bias), blinding of outcome assessment (detection bias), incomplete outcome data (attrition bias), selective reporting (reporting bias), and other bias.

Data analysis
-------------

Due to the poor homogeneity of the included publications, only descriptive analysis was conducted in the present study.

Results
=======

Description of the assessed publications
----------------------------------------

A total of 3,231 abstracts (2,953 in Chinese and 278 in English) were selected from nine databases; 1,154 studies were excluded for duplication. According to the exclusion criteria, screening of the titles and abstracts resulted in the removal of 1,948 articles. Full-text review of the remaining 129 publications indicated that 13 studies met the inclusion criteria and they were enrolled into the final analysis.[@b8-dddt-10-107]--[@b11-dddt-10-107],[@b15-dddt-10-107]--[@b23-dddt-10-107] The flowchart displayed in [Figure 1](#f1-dddt-10-107){ref-type="fig"} shows the detailed selection process.

To share more information with regard to this topic, part of excluded articles were provided as Supplementary material.

Characteristics of the studies
------------------------------

The characteristics of the 13 studies are summarized in [Table 1](#t1-dddt-10-107){ref-type="table"}. A total of 1,515 RAS patients were studied in this review. The sample size ranged from 15 to 150 patients in each study. Twelve different types of herbal medicine, in the form of gargles, membranes, powders, tablets, toothpastes, and gelatin preparations, were used, among which eight were traditional Chinese medicines and four were Iranian herbal medicines. The experimental period in these trials ranged from 3 to 10 days, with an average time of 5.92±2.21 days.

Risk of bias and quality assessment of the studies
--------------------------------------------------

Among the included studies, 12 were RCTs and one was self-controlled. The quality of over 50% of enrolled studies was rated as poor, according to the Cochrane quality assessment criteria ([Table 2](#t2-dddt-10-107){ref-type="table"} and [Figure 2](#f2-dddt-10-107){ref-type="fig"}).

Effects of the interventions
----------------------------

Due to the heterogeneity of the enrolled trials, only descriptive analysis was conducted in this study.

Main outcome measure
--------------------

The main outcome measures assessed in this study were ulcer size, lesion duration, and remission of pain.

### Size of ulcer

Four out of 13 trials reported a change in ulcer size, which was measured by different methods. Haghpanah et al[@b11-dddt-10-107] evaluated the average diameter of all ulcers; however, Jiang et al[@b10-dddt-10-107] and Liu[@b23-dddt-10-107] evaluated the maximum diameter of the ulcer, while Liu et al[@b8-dddt-10-107] determined the size of the ulcer by the maximum diameter and its vertical diameter. Nevertheless, all the studies reported a statistically significant reduction of the ulcer size in patients receiving herbal medicine therapy compared with the controls, with the exception of the study by Haghpanah et al,[@b11-dddt-10-107] who reported that a significant difference between the herbal medicine group and the control group was only observed in the first day of the intervention, with no statistically significant differences between the groups for the remaining time points.

### Duration of ulcer

Four trials reported data on the duration of the ulcer. Ghalayani et al[@b16-dddt-10-107] reported a significant difference in the mean healing time between 8.6±0.99 days of placebo treatment and 5.3±0.81 days of treatment with *Punica granatum* extract (*P*\<0.001). In the study by Liu et al,[@b22-dddt-10-107] it was found that Tian-zhu aerosol oral rinse remarkably reduced the duration of the ulcer compared with chlorhexidine rinse (*P*\<0.05); however, no detailed information was described. In the study by Amanlou et al,[@b15-dddt-10-107] the average time for complete healing of the lesions in patients receiving *Satureja khuzestanica* extract or its essential oil was 5.90±1.24 days and 6.85±1.3 days, respectively, which were both significantly less than those receiving placebo treatment (10.40±1.66 days, *P*=0.0001). Moreover, there was no significant difference between the experimental groups. In the study by Wei and Li,[@b21-dddt-10-107] the healing time of the lesions in patients receiving Fufangjiaolianzhiji (2.79±0.30 days) was significantly shorter than when patients received a chlorhexidine rinse (6.02±1.45 days, *P*\<0.05).

### Remission of pain

Remission of pain was described in all the trials included in this literature review and it was described as the main outcome index in six studies. In addition, a visual analog scale (VAS) was applied in five out of the six studies to record the level of pain. In these studies, the visual analog scale score was significantly decreased in the herbal medicine groups than in the control groups.[@b8-dddt-10-107]--[@b11-dddt-10-107],[@b16-dddt-10-107] In addition, two trials reported the average period of pain elimination, which was significantly shorter in patients receiving herbal medicine than placebo treatment.[@b15-dddt-10-107],[@b16-dddt-10-107]

Side effects
------------

Five trials did not report side effects,[@b9-dddt-10-107],[@b16-dddt-10-107],[@b18-dddt-10-107],[@b21-dddt-10-107],[@b22-dddt-10-107] while five trials reported that there were no side effects[@b10-dddt-10-107],[@b11-dddt-10-107],[@b17-dddt-10-107],[@b19-dddt-10-107],[@b23-dddt-10-107] and three trials reported slight side effects.[@b8-dddt-10-107],[@b15-dddt-10-107],[@b20-dddt-10-107] In the study by Liu et al,[@b20-dddt-10-107] one patient receiving herbal medicine and one patient in the control group reported side effects, but no detailed information was provided. In the study by Amanlou et al,[@b15-dddt-10-107] two participants reported a slight burning sensation after receiving *S. khuzestanica* essential oil (prepared in an ethanol/water mixture: 50% v/v) on the first application. Liu et al[@b8-dddt-10-107] noted that two patients in the placebo group complained of slight lingual numbness, which spontaneously remedied.

Discussion
==========

RAS is one of the most common oral disorders and its etiology is not well understood. Its management is mainly directed toward symptomatic, supportive treatment.[@b3-dddt-10-107] Therefore, corticosteroids and analgesics serve as the first choice for RAS patients.[@b4-dddt-10-107] However, longer treatment times and frequent exposure to such drugs may induce severe complications, such as secondary fungal infections and drug resistance.[@b5-dddt-10-107] There has been a long history of the use of natural herbal medicines for various disorders, including RAS, worldwide and such remedies have been studied both in clinic trials and experimental studies.[@b8-dddt-10-107],[@b9-dddt-10-107],[@b24-dddt-10-107],[@b25-dddt-10-107] In this study, we focused on the efficacy and safety of the topical application of natural herbal medicines for the treatment of RAS.

A total of 1,515 subjects in 13 clinical trials were analyzed in the present analysis. Compared with controls, topical natural herbal medicines greatly improved the patients' symptoms by reducing ulcer size, shortening ulcer duration, and relieving pain without severe complications. However, only a weak conclusion can be drawn due to several limitations. First, the homogeneity of the studies was quite poor, with variables such as the various types of treatment, dosage, formula, application method, sample size, and experiment duration. Second, the quality of the studies was not sufficient because of poor study design and high risks in the performance, detection, attrition, and reporting bias. Therefore, a meta-analysis could not be conducted based on the current data. Consequently, this analysis unveiled the need for well-designed multicenter RCTs, which are of paramount importance for further exploration. Furthermore, precise criteria and standard methodologies should be established to ensure high-quality data.

The rationale of study designs can be a guarantee of strong clinical trials. The herbal medicine--oriental model or disease--oriental model may greatly affect the inclusion and exclusion criteria of future meta-analyses.

Detailed information of the herbal medicine used in future studies, including the formula, dosage, therapy duration, application protocols, and control intervention, should be provided. If possible, the dosage and application protocol should be homogenized for different forms of the same medicine.

In the studies included in this review, the therapy duration ranged from 3 to 10 days. However, we found that the natural course of an untreated ulcer was 9.5±1.3 days[@b15-dddt-10-107],[@b16-dddt-10-107] and the duration of herbal medicine treatment was 5.21±1.73 days.[@b15-dddt-10-107],[@b16-dddt-10-107],[@b21-dddt-10-107],[@b22-dddt-10-107] It is therefore suggested that the experimental period should exceed 7 days to avoid missing valuable data. Moreover, follow-up is highly recommended.

In addition to the above, the index and measurement of outcomes should be described clearly and consistently in future studies. According to the current data, ulcer size, lesion duration, and level of pain are commonly considered as the main outcome indicators. However, researchers often failed to assess them in a standard way, especially with regards to the ulcer size. Actually, manifestation of RAS may be a single ulcer or several round or elliptic recurrent ulcers in the oral mucosa.[@b4-dddt-10-107] Therefore, measurement of the maximum diameter may not be suitable to determine the ulcer size accurately. Theoretically, evaluation of the ulcer area may be better in describing the lesion size; however, the precise calculation may restrict its application in clinic. We suggest that measurement of the maximum diameter and its vertical diameter should be made, as described in the study by Liu et al,[@b8-dddt-10-107] as it is a precise and convenient way to determine the size of lesions. Finally, appropriate statistical methods also represent an important part of study protocols and can allow sample size calculation and data analysis.

In summary, the current data show favorable benefits of the topical treatment of RAS with natural herbal medicines and only three of the included studies reported slight and/or transient side effects during the clinical trial period. Thus, there is some evidence to suggest that topical herbal medicine therapy is an effective and safe alternative option to current Western medicine-based treatments for RAS.

Conclusion
==========

There is weak evidence with regards to the efficacy of the topical application of natural herbal medicines for the treatment of RAS patients' conditions, with few side effects reported. However, given the limitations of the trials included in this assessment and the methodologies employed in the current data, a definitive conclusion cannot be drawn. Well-designed and high-quality RCTs are required for further exploration.
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###### 

Characteristics of the enrolled studies

  Study   Authors           Year   Article source                                                                            Type of study     Sample size (treatment/control)        Med ications/formu la
  ------- ----------------- ------ ----------------------------------------------------------------------------------------- ----------------- -------------------------------------- ------------------------------------------------------------------
  8       Liu et al         2012   *Evidence-based Complementary Alternative Medicine*, 2012;2012:284620                     RCT               33/28                                  Yunnan Baiyao/toothpaste
  9       Gavanji et al     2014   *Integrative Medicine Research*, 2014;3(2):83--90                                         RCT               210 patients in 7 groups, 30 in each   Alcoholic and water extracts of *Punica granatum*
  10      Jiang et al       2013   *Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology*, 2013; 115(2):212--217   RCT               42/42                                  Berberine/gelatin
  11      Haghpanah et al   2015   *Caspian Journal of Internal Medicine*, 2015;6(1):3--8                                    Self-controlled   15/15                                  *Zingiber officinale* extract/mucoadhesives
  15      Amanlou et al     2007   *Daru*, 2007;15(4):231--235                                                               RCT               20/20                                  *Satureja khuzestanica* extract and its oil preparation/solution
  16      Ghalayani et al   2013   *Journal of Research Pharmacy Practice*, 2013;2(2):88--92                                 RCT               20/20                                  *P. granatum* extract/gelatin
  17      Wu                2000   *Journal of Clinical Stomatology*, 2000;16(3):172--173                                    RCT               150/130                                Nourishing Yin and promoting granulation membrane formula
  18      Han and Zhang     2003   *Journal of Zhengzhou University* (*Medical Sciences*), 2003;38(5):810--811               RCT               88/88                                  Qingmei ulcer membrane
  19      Huang et al       1996   *Jin Ling Yi Yuan Xue Bao*, 1996;9(2):173--174                                            RCT               33/28                                  Nourishing Yin and promoting granulation membrane formula
  20      Liu et al         2006   *Journal of TCM University of Human*, 2006;26(3):36--37                                   RCT               58/58                                  KouChuangNing tablets
  21      Wei and Li        2003   *Shan Xi Zhong Yi*, 2003;23(8):714--725                                                   RCT               63/58                                  Fufangjiaolianzhiji/membrane
  22      Liu et al         2013   *Journal of Chengdu University of TCM*, 2013;36(4):80--82                                 RCT               43/40                                  Tian-zhu aerosol oral rinse
  23      Liu               2010   *Chinese Journal of Misdiagnosis*, 2010;10(28):6826                                       RCT               36/36                                  Kangfuxinye/gargle

       Interventions                                                                                                                                                                                                                                                                                       
  ---- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------
  8    Teeth brushed with Yunnan Baiyao toothpaste twice daily; 1 g toothpaste for 3 minutes, for 5 days                                                                                                                                                                                                   Same procedure with placebo toothpaste
  9    Mouth rinsed with alcoholic and water extracts of *P. granatum* var Pleni-flora, *P. granatum* var Sweet Alak, and *P. granatum* var Saveh Black for 10 minutes, four times daily, for 10 days                                                                                                      Negative control received no treatment
  10   Berberine gelatin dabbed onto the ulcer for 30 minutes, four times daily, for 5 days                                                                                                                                                                                                                Same procedure with placebo gelatin
  11   Stage 1: patients received placebo mucoadhesive, applied for 20 minutes, four times daily, for 7 days; stage 2: delayed until next RAS episode, then patients received mucoadhesive containing *Z. officinale* alcoholic extract, which was applied for 20 minutes, four times daily, for 7 days    
  15   A small, sterile cotton pad impregnated with five drops of hydroalcoholic extracts (25%) of *S. khuzestanica* solution or its essential oil preparation was applied to the lesions for 1 minute and patients then fasted for at least 30 minutes; procedure repeated four times daily, for 7 days   Same procedure with hydroalcoholic solution in the absence of any active material
  16   A small, sterile cotton pad impregnated with a hydroalcoholic extract of *P. granatum* flowers was applied to the lesions for 1 minute and the patients then fasted for at least 30 minutes; procedure repeated three times daily, for 7 days                                                       Same procedure with placebo gel
  17   Nourishing Yin and promoting granulation membrane formula was applied to the lesions four times daily, for 5 days                                                                                                                                                                                   Same procedure with chlorhexidine membrane
  18   Qingmei ulcer membrane was applied to the lesions four times daily, for 5 days                                                                                                                                                                                                                      Oral administration of vitamin B2 (10 mg) and vitamin C (300 mg) three times daily
  19   Qingmei ulcer membrane was applied to the lesions four times daily, for 5 days                                                                                                                                                                                                                      Same procedure with chlorhexidine membrane
  20   KouChuangNing tablets (1.0 g) were held in the mouth until dissolved every 2 hours, six times per day, for 5 days                                                                                                                                                                                   Same procedure with placebo tablets
  21   Fufangjiaolianzhiji membrane was applied to the lesions, for 3 days                                                                                                                                                                                                                                 Same procedure with chlorhexidine membrane
  22   Mouth rinsed with natural saline twice; 10 minutes later, Tian-zhu aerosol oral rinse was used for 5 minutes; procedure repeated four times daily, for 10 days                                                                                                                                      Same procedure with chlorhexidine rinse
  23   Mouth rinsed with Kangfuxinye for 1--2 minutes, three times daily, for 3 days                                                                                                                                                                                                                       Same procedure with natural saline

       Treatment course   Outcome measurement                                                                                      Complication                                                                                                                           Follow-up
  ---- ------------------ -------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------
  8    5 days             Ulcer size (maximum diameter × vertical diameter) and pain level (VAS)                                   Two patients in the placebo group complained of lingual numbness, which spontaneously resolved                                         Not mentioned
  9    10 days            Pain level and the degree of the participants' satisfaction (VAS)                                        Not mentioned                                                                                                                          Not mentioned
  10   5 days             Ulcer size (maximum diameter) and pain level (VAS)                                                       None                                                                                                                                   Not mentioned
  11   7 days             Ulcer size (average diameter), the diameter of lesions and the inflammatory zone, and pain level (VAS)   None                                                                                                                                   Not mentioned
  15   7 days             Duration for complete healing and duration of elimination of pain                                        Two participants reported a slight burning sensation after receiving S. *khuzestanica* essential oil                                   7 days
  16   7 days             Pain level (VAS), duration for complete healing, and duration of elimination of pain                     Not mentioned                                                                                                                          Until complete healing
  17   5 days             Healing rate                                                                                             None                                                                                                                                   Not mentioned
  18   5 days             Healing rate                                                                                             Not mentioned                                                                                                                          Not mentioned
  19   5 days             Healing rate                                                                                             None                                                                                                                                   Not mentioned
  20   5 days             Healing rate                                                                                             One case in the experimental group and one case in the control group reported side effects, but no detailed information was provided   Not mentioned
  21   3 days             Healing rate                                                                                             Not mentioned                                                                                                                          Yes, but without detailed information
  22   10 days            Healing rate, recurrence rate within 1 year, and duration for complete healing                           Not mentioned                                                                                                                          1 year
  23   3 days             Level of pain, ulcer size (maximum diameter), degree of erythema, and healing rate                       None                                                                                                                                   Not mentioned

**Abbreviations:** RAS, recurrent aphthous stomatitis; RCT, randomized controlled trial; VAS, visual analog scale.

###### 

Quality assessment of included studies

  Study   Random sequence generation   Allocation concealment   Blinding of participants and personnel   Blinding of outcome assessment   Incomplete outcome data   Selective reporting   Other bias
  ------- ---------------------------- ------------------------ ---------------------------------------- -------------------------------- ------------------------- --------------------- ------------
  8       Low bias                     Low bias                 Low bias                                 Low bias                         Low bias                  Low bias              Uncertain
  9       Uncertain                    Low bias                 Low bias                                 Low bias                         Low bias                  Low bias              Uncertain
  10      Uncertain                    Low bias                 Low bias                                 Low bias                         Low bias                  Low bias              Uncertain
  11      Uncertain                    Low bias                 Low bias                                 Low bias                         Low bias                  Low bias              Uncertain
  15      Uncertain                    Uncertain                Low bias                                 Low bias                         Low bias                  Low bias              Uncertain
  16      Uncertain                    Low bias                 Low bias                                 Low bias                         Low bias                  Low bias              Uncertain
  17      Low bias                     Uncertain                Low bias                                 Low bias                         High bias                 High bias             Uncertain
  18      Low bias                     Uncertain                High bias                                High bias                        Low bias                  Low bias              Uncertain
  19      Uncertain                    Uncertain                High bias                                High bias                        High bias                 High bias             Uncertain
  20      Low bias                     Low bias                 Low bias                                 Low bias                         High bias                 High bias             Uncertain
  21      Low bias                     Uncertain                High bias                                High bias                        Low bias                  Low bias              Uncertain
  22      Uncertain                    Uncertain                High bias                                High bias                        Low bias                  Low bias              Uncertain
  23      Uncertain                    Uncertain                High bias                                High bias                        High bias                 High bias             Uncertain
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